Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov page's footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:46:26.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    0.8%
    Check dated 2026-10-24T16:24:55.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T16:13:03.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site’s displayed revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T16:08:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the older revision v3.6.6 was removed from the list, reflecting updates to the record's version history.
    Difference
    0.1%
    Check dated 2026-09-19T21:54:36.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) was added to the Study Record Versions, updating the revision history to reflect the latest state of the record. The previous revision (v3.6.5) was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-29T19:00:10.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.